Last reviewed · How we verify

NCT04719312

Y Transconjunctival Approach in Open Reduction of Zygomatic Maxillary Complex Fracture

Completed NA Last updated 22 January 2021
What this trial tests

NA trial testing Y modification of transconjunctival approach in Zygomatic Fractures in 15 participants. Completed in 7 October 2020.

Timeline
3 March 2019
Primary endpoint
7 October 2020
7 October 2020

Quick facts

Lead sponsorHams Hamed Abdelrahman
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date3 March 2019
Primary completion7 October 2020
Estimated completion7 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Hams Hamed Abdelrahman — full company profile →

Who can join

Adults 20 to 50, any sex, with Zygomatic Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study was made on fifteen patients who will undergo fracture repair of the zygomaticomaxillary complex. Postoperative patient evaluation performed with specific attention paid towards, accessibility the exposure duration(time from incision till exposure of the field), esthetic appearance, post-operative pain, post-operative edema, orbital movement, wound healing, scarring infection, and the post-operative ocular complications such as ectropion, entropion, enophthalmos, scleral show and corneal abrasion. Postoperative clinical examinations along with radiographic examination was done to evaluate the position of zygoma and determine the adequacy of fracture reduction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Zygomatic Fractures

Currently open trials in the same condition.

Other Hams Hamed Abdelrahman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing